These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

201 related items for PubMed ID: 38097715

  • 1. Sigma-1 receptor activation mediates the sustained antidepressant effect of ketamine in mice via increasing BDNF levels.
    Ma H, Li JF, Qiao X, Zhang Y, Hou XJ, Chang HX, Chen HL, Zhang Y, Li YF.
    Acta Pharmacol Sin; 2024 Apr; 45(4):704-713. PubMed ID: 38097715
    [Abstract] [Full Text] [Related]

  • 2. IGF-1 release in the medial prefrontal cortex mediates the rapid and sustained antidepressant-like actions of ketamine.
    Deyama S, Kondo M, Shimada S, Kaneda K.
    Transl Psychiatry; 2022 May 17; 12(1):178. PubMed ID: 35577782
    [Abstract] [Full Text] [Related]

  • 3. Cortical and raphe GABAA, AMPA receptors and glial GLT-1 glutamate transporter contribute to the sustained antidepressant activity of ketamine.
    Pham TH, Defaix C, Nguyen TML, Mendez-David I, Tritschler L, David DJ, Gardier AM.
    Pharmacol Biochem Behav; 2020 May 17; 192():172913. PubMed ID: 32201299
    [Abstract] [Full Text] [Related]

  • 4. Medial PFC AMPA receptor and BDNF signaling are required for the rapid and sustained antidepressant-like effects of 5-HT1A receptor stimulation.
    Fukumoto K, Fogaça MV, Liu RJ, Duman CH, Li XY, Chaki S, Duman RS.
    Neuropsychopharmacology; 2020 Sep 17; 45(10):1725-1734. PubMed ID: 32396921
    [Abstract] [Full Text] [Related]

  • 5. Neurotrophic mechanisms underlying the rapid and sustained antidepressant actions of ketamine.
    Deyama S, Duman RS.
    Pharmacol Biochem Behav; 2020 Jan 17; 188():172837. PubMed ID: 31830487
    [Abstract] [Full Text] [Related]

  • 6. The mood stabilizer lithium potentiates the antidepressant-like effects and ameliorates oxidative stress induced by acute ketamine in a mouse model of stress.
    Chiu CT, Scheuing L, Liu G, Liao HM, Linares GR, Lin D, Chuang DM.
    Int J Neuropsychopharmacol; 2014 Dec 28; 18(6):. PubMed ID: 25548109
    [Abstract] [Full Text] [Related]

  • 7. Activity-dependent brain-derived neurotrophic factor signaling is required for the antidepressant actions of (2R,6R)-hydroxynorketamine.
    Fukumoto K, Fogaça MV, Liu RJ, Duman C, Kato T, Li XY, Duman RS.
    Proc Natl Acad Sci U S A; 2019 Jan 02; 116(1):297-302. PubMed ID: 30559184
    [Abstract] [Full Text] [Related]

  • 8. Partial mGlu5 receptor NAM, M-5MPEP, induces rapid and sustained antidepressant-like effects in the BDNF-dependent mechanism and enhances (R)-ketamine action in mice.
    Pałucha-Poniewiera A, Rafało-Ulińska A, Santocki M, Babii Y, Kaczorowska K.
    Pharmacol Rep; 2024 Jun 02; 76(3):504-518. PubMed ID: 38632187
    [Abstract] [Full Text] [Related]

  • 9. Microglial ERK-NRBP1-CREB-BDNF signaling in sustained antidepressant actions of (R)-ketamine.
    Yao W, Cao Q, Luo S, He L, Yang C, Chen J, Qi Q, Hashimoto K, Zhang JC.
    Mol Psychiatry; 2022 Mar 02; 27(3):1618-1629. PubMed ID: 34819637
    [Abstract] [Full Text] [Related]

  • 10. Comparison of R-ketamine and rapastinel antidepressant effects in the social defeat stress model of depression.
    Yang B, Zhang JC, Han M, Yao W, Yang C, Ren Q, Ma M, Chen QX, Hashimoto K.
    Psychopharmacology (Berl); 2016 Oct 02; 233(19-20):3647-57. PubMed ID: 27488193
    [Abstract] [Full Text] [Related]

  • 11. Comparison of ketamine, 7,8-dihydroxyflavone, and ANA-12 antidepressant effects in the social defeat stress model of depression.
    Zhang JC, Yao W, Dong C, Yang C, Ren Q, Ma M, Han M, Hashimoto K.
    Psychopharmacology (Berl); 2015 Dec 02; 232(23):4325-35. PubMed ID: 26337614
    [Abstract] [Full Text] [Related]

  • 12. AMPA Receptor Activation-Independent Antidepressant Actions of Ketamine Metabolite (S)-Norketamine.
    Yang C, Kobayashi S, Nakao K, Dong C, Han M, Qu Y, Ren Q, Zhang JC, Ma M, Toki H, Yamaguchi JI, Chaki S, Shirayama Y, Nakazawa K, Manabe T, Hashimoto K.
    Biol Psychiatry; 2018 Oct 15; 84(8):591-600. PubMed ID: 29945718
    [Abstract] [Full Text] [Related]

  • 13. BDNF release and signaling are required for the antidepressant actions of GLYX-13.
    Kato T, Fogaça MV, Deyama S, Li XY, Fukumoto K, Duman RS.
    Mol Psychiatry; 2018 Oct 15; 23(10):2007-2017. PubMed ID: 29203848
    [Abstract] [Full Text] [Related]

  • 14. TAK-653, an AMPA receptor potentiator with minimal agonistic activity, produces an antidepressant-like effect with a favorable safety profile in rats.
    Hara H, Suzuki A, Kunugi A, Tajima Y, Yamada R, Kimura H.
    Pharmacol Biochem Behav; 2021 Dec 15; 211():173289. PubMed ID: 34655652
    [Abstract] [Full Text] [Related]

  • 15. Ketamine-induced antidepressant effects are associated with AMPA receptors-mediated upregulation of mTOR and BDNF in rat hippocampus and prefrontal cortex.
    Zhou W, Wang N, Yang C, Li XM, Zhou ZQ, Yang JJ.
    Eur Psychiatry; 2014 Sep 15; 29(7):419-23. PubMed ID: 24321772
    [Abstract] [Full Text] [Related]

  • 16. The duration of the antidepressant-like effects of a single infusion of brain-derived neurotrophic factor into the medial prefrontal cortex in mice.
    Deyama S, Kaneda K.
    Behav Brain Res; 2020 Sep 15; 394():112844. PubMed ID: 32745661
    [Abstract] [Full Text] [Related]

  • 17. Rapid and Sustained Antidepressant Action of the mGlu2/3 Receptor Antagonist MGS0039 in the Social Defeat Stress Model: Comparison with Ketamine.
    Dong C, Zhang JC, Yao W, Ren Q, Ma M, Yang C, Chaki S, Hashimoto K.
    Int J Neuropsychopharmacol; 2017 Mar 01; 20(3):228-236. PubMed ID: 27765808
    [Abstract] [Full Text] [Related]

  • 18. Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.
    Deyama S, Aoki S, Sugie R, Fukuda H, Shuto S, Minami M, Kaneda K.
    Neurotherapeutics; 2023 Mar 01; 20(2):484-501. PubMed ID: 36622634
    [Abstract] [Full Text] [Related]

  • 19. VGF and its C-terminal peptide TLQP-62 in ventromedial prefrontal cortex regulate depression-related behaviors and the response to ketamine.
    Jiang C, Lin WJ, Labonté B, Tamminga CA, Turecki G, Nestler EJ, Russo SJ, Salton SR.
    Neuropsychopharmacology; 2019 Apr 01; 44(5):971-981. PubMed ID: 30504797
    [Abstract] [Full Text] [Related]

  • 20. Fast antidepressant action of ketamine in mouse models requires normal VGLUT1 levels from prefrontal cortex neurons.
    Belloch FB, Cortés-Erice M, Herzog E, Zhang XM, Díaz-Perdigon T, Puerta E, Tordera RM.
    Prog Neuropsychopharmacol Biol Psychiatry; 2023 Mar 08; 121():110640. PubMed ID: 36209771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.